Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH StudyTakao Takeshima, Hideaki Katagiri, Kaname Ueda et al.|Advances in Therapy|2026Cited by 0